MP-IV Trademark

Trademark Overview

On Tuesday, September 10, 2019, a trademark application was filed for MP-IV with the United States Patent and Trademark Office. The USPTO has given the MP-IV trademark a serial number of 88611008. The federal status of this trademark filing is REGISTERED as of Tuesday, July 13, 2021. This trademark is owned by MedUX LLC. The MP-IV trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time
mp-iv

General Information

Serial Number88611008
Word MarkMP-IV
Filing DateTuesday, September 10, 2019
Status700 - REGISTERED
Status DateTuesday, July 13, 2021
Registration Number6420653
Registration DateTuesday, July 13, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2020

Trademark Statements

Goods and ServicesMedical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, September 19, 2019
Primary Code010
First Use Anywhere DateSunday, April 25, 2021
First Use In Commerce DateSunday, April 25, 2021

Trademark Owner History

Party NameMedUX LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSyracuse, NY 13210
Party NameMedUX LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSyracuse, NY 13210
Party NameMedUX LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSyracuse, NY 13210

Trademark Events

Event DateEvent Description
Tuesday, July 13, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 8, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, June 5, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 12, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, April 30, 2021USE AMENDMENT FILED
Wednesday, May 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 30, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, February 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 22, 2021EXTENSION 2 GRANTED
Monday, February 22, 2021EXTENSION 2 FILED
Monday, February 22, 2021TEAS EXTENSION RECEIVED
Friday, September 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 23, 2020EXTENSION 1 GRANTED
Wednesday, September 23, 2020EXTENSION 1 FILED
Wednesday, September 23, 2020TEAS EXTENSION RECEIVED
Tuesday, March 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2019ASSIGNED TO EXAMINER
Thursday, September 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 13, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

solutions amounts bloodstream over time measured delivering devices namely infusion